Machine Learning Enhancement of Flow Cytometry Data Accelerates the Identification of Minimal Residual Acute Myeloid Leukemia

被引:0
|
作者
Seheult, Jansen N. [1 ]
Shi, Min [1 ]
Olteanu, Horatiu [1 ]
Otteson, Gregory E. [1 ]
Timm, Michael M. [1 ]
Weybright, Matthew J. [1 ]
Horna, Pedro [1 ]
机构
[1] Mayo Clin, Div Hematopathol, Rochester, MN USA
关键词
D O I
10.1182/blood-2023-190275
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Assessment Of Minimal Residual Disease In Acute Myeloblastic Leukemia In Multiparameter Flow Cytometry
    Lacombe, Francis
    Allou, Kaoutar
    Arnoulet, Christine
    Campos, Lydia
    de Labarthe, Adrienne
    Dumezy, Florent
    Feuillard, Jean
    Genevieve, Franck
    Guerin, Estelle
    Guy, Julien
    Jouault, Helene
    Lepelley, Pascale
    Maynadie, Marc
    Solly, Francoise
    Ballonn, Orianne Wagner
    Preudhomme, Claude
    Baruchel, Andre
    Dombret, Herve
    Ifrah, Norbert
    Bene, Marie C.
    BLOOD, 2013, 122 (21)
  • [32] DETECTION OF MINIMAL RESIDUAL DISEASE IN ACUTE-LEUKEMIA BY FLOW-CYTOMETRY
    VISSER, JWM
    MARTENS, ACM
    HAGENBEEK, A
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1986, 468 : 268 - 275
  • [33] Flow cytometry for minimal residual disease testing in acute leukemia: opportunities and challenges
    Gaipa, Giuseppe
    Buracchi, Chiara
    Biondi, A.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2018, 18 (09) : 775 - 787
  • [34] Reproducibility of measurable residual disease detection by flow cytometry in acute myeloid leukemia
    Roehnert, M. A.
    Kramer, M.
    Schadt, J.
    Ensel, P.
    Thiede, C.
    Krause, S.
    Buecklein, V
    Hoffmann, J.
    Jaramillo, S.
    Schlenk, R.
    Roellig, C.
    Bornhaeuser, M.
    McCarthy, N.
    Freeman, S.
    Oelschlaegel, U.
    von Bonin, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 278 - 278
  • [35] Clinical Analysis and Optimization of Postremission Therapy for Acute Myeloid Leukemia Patients with Minimal Residual Disease as Determined by Flow Cytometry
    Inoue, Daichi
    Maruoka, Hayato
    Takahashi, Takayuki
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2010, 2 (02)
  • [36] Determination of minimal residual disease in patients with acute myeloid leukemia by multiparameter flow cytometry: Prognostic impact at different checkpoints
    Kern, W
    Voskova, D
    Schoch, C
    Hiddemann, W
    Schnittger, S
    Haferlach, T
    BLOOD, 2004, 104 (11) : 117A - 117A
  • [37] Validation of a 12-color flow cytometry assay for acute myeloid leukemia minimal/measurable residual disease detection
    Wang, Sa A.
    Jorgensen, Jeffrey L.
    Hu, Shimin
    Jia, Fuli
    Li, Shaoying
    Loghavi, Sanam
    Ok, Chi Young
    Thakral, Beenu
    Xu, Jie
    Medeiros, L. Jeffrey
    Wang, Wei
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2023, 104 (05) : 356 - 366
  • [38] MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA DETECTED BY WILMS TUMOR GENE 1 EXPRESSION AND MULTIPARAMETER FLOW CYTOMETRY
    Frairia, C.
    Aydin, S.
    Riera, L.
    Aliberti, S.
    Allione, B.
    Audisio, E.
    Stefano, D.
    Demurtas, A.
    di Celle, P. Francia
    Nicolino, B.
    Pecoraro, C.
    Stacchini, A.
    Marmont, F.
    Vitolo, U.
    HAEMATOLOGICA, 2014, 99 : 304 - 304
  • [39] Comparison Between Multiparameter Flow Cytometry and Cytogenetic/Molecular Test for Detection of Minimal Residual Disease in Acute Myeloid Leukemia
    Wang, Xiaohua
    Lanier, Virginia
    Pataroque, Kaitlin
    Fan, Guang
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 144 : A137 - A137
  • [40] Persistence of minimal residual disease assessed by multiparameter flow cytometry is highly prognostic in younger patients with acute myeloid leukemia
    Ravandi, Farhad
    Jorgensen, Jeffrey
    Borthakur, Gautam
    Jabbour, Elias
    Kadia, Tapan
    Pierce, Sherry
    Brandt, Mark
    Wang, Sa
    Konoplev, Sergej
    Wang, Xuemei
    Huang, Xuelin
    Daver, Naval
    DiNardo, Courtney
    Andreeff, Michael
    Konopleva, Marina
    Estrov, Zeev
    Garcia-Manero, Guillermo
    Cortes, Jorge
    Kantarjian, Hagop
    CANCER, 2017, 123 (03) : 426 - 435